Ga] generator. The influences of peptide concentration, pH, and temperature on the radiolabeling efficiency were studied. The stability was evaluated in saline, human serum, DTPA, transferrin, and metallic ions (FeCl 3 , CaCl 2 , and ZnCl 2 ). Cell binding assay was performed using human breast cancer cells (T47D). Tissue biodistribution was studied in normal athymic nude mice. Results: Optimal radiolabeling (>95.0%) of the DOTA-peptide conjugates required a higher (50°C-90°C) temperature and 10 minutes of incubation at pH 2-5. The NODAGA-peptide conjugate needed incubation only at 25°C for 10 minutes. Both radiocomplexes were stable in saline, serum, as well as against transchelation and transmetallation. Cell binding at 37°C for 15 minutes of incubation with 68 Ga-NODAGA-peptide was 34.0% compared to 24.5% for 68 Ga-DOTA-peptide. Tissue biodistribution at 1 hour postinjection of both 68 Ga-labeled peptide conjugates showed clearance through the kidneys. Conclusions: NODAGA-peptide showed more convenient radiolabeling features than that of DOTA-peptide.